Triple-combination therapy with cyclosporine, antithymocyte serum, and silica in pancreatic islet xenografting.
Kanehiro
H
H
Department of Surgery, Nara Medical University, Japan.
Nakano
H
H
Nakajima
Y
Y
Segawa
M
M
Murao
Y
Y
Nakagawa
K
K
Shiratori
T
T
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006224:Cricetinae; D003524:Cyclosporins / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects*; D016381:Islets of Langerhans Transplantation; D008297:Male; D008647:Mesocricetus; D051381:Rats; D011919:Rats, Inbred Strains; D012822:Silicon Dioxide / Q000627:therapeutic use*; D014183:Transplantation, Heterologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D012822:Silicon Dioxide